
Animal data drives most preclinical decisions. But it doesn't predict human biology.
Species differences routinely mask the toxicity and efficacy signals that only surface once a program reaches human trials.
By then, the cost of being wrong is measured in years and millions. The FDA Modernization Act now allows non-animal data in regulatory submissions — opening the door to models built on real human tissue.


Modular microfluidic system with perfused capillary networks connecting multiple organ types.
Learn more →

Multilayered gradient device generating topographically organized cerebral organoids.
Learn more →

Stem-cell-derived placental organoids integrated with vascular microfluidics.
Learn more →
Two granted patents, with a third pending, on perfused multi-organ vasculature.


Founded by Srujana Cherukuri, PhD, with co-inventors from UC Irvine's vascular biology, neurodevelopment, and biomedical engineering labs.
